FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

757951000168101: Macu-Vision (ascorbic acid 250 mg + cupric oxide 1.25 mg + d-alpha-tocopheryl acid succinate 165 mg + zinc oxide 49.8 mg) tablet, 150 tablets (trade product pack)


Status: current, Defined. Date: 29-Feb 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3856431000168110 Macu-Vision tablet, 150 en Synonym Active Case sensitive Australian Medicines Terminology module
3876461000168117 Macu-Vision (ascorbic acid 250 mg + cupric oxide 1.25 mg + d-alpha-tocopheryl acid succinate 165 mg + zinc oxide 49.8 mg) tablet, 150 tablets (trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Macu-Vision tablet, 150 Is a trade product pack true Inferred relationship Some
Macu-Vision tablet, 150 Is a ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) tablet, 150 true Inferred relationship Some
Macu-Vision tablet, 150 has TPUU Macu-Vision tablet true Inferred relationship Some 1
Macu-Vision tablet, 150 has TP Macu-Vision true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Macu-Vision tablet, 150, bottle Is a True Macu-Vision tablet, 150 Inferred relationship Some

Reference Sets

Description inactivation indicator reference set

Trade product pack reference set

Back to Start